Redwood AI’s Stock Plunges 62% Despite Government Contracts and Quantum Deal Ambitions

The divergence between Redwood AI’s corporate narrative and its stock performance is growing wider by the week. While the company has rolled out a stream of announcements — from government-backed chemical safety projects to a potential quantum-cryptography acquisition — its shares have been hammered. The equity now trades 62% below its 52-week high, having collapsed nearly 51% since the start of May alone. On Monday, the stock closed at CAD 3.80, down 5% over the prior seven days, with annualised 30-day volatility clocking in at a staggering 114%.

Behind the price action lies a flurry of news that has failed to win over investors. A central plank of Redwood’s pitch is its AI-driven chemistry platform, Reactosphere, which the company says now evaluates more than 21 million chemical reactions — up from

roughly four million earlier this year. The system is trained on over a billion molecules, a scale that has opened the door to a research partnership with the University of British Columbia and a collaboration with Resilience Biosciences that began in May to develop new drugs. On the government side, Redwood’s Q-SAFE programme — designed to classify hazardous chemicals for defence and security applications — secured up to CAD 240,000 in advisory services and funding from the National Research Council of Canada. That project also involves the Royal Canadian Mounted Police and border services in detecting toxic opioids, with backing from state research grants.

Yet the operational milestones remain overshadowed by a lack of hard commercial results. Redwood only listed on the Canadian Securities Exchange on 6 February 2026, giving it a brief trading history with roughly 35.9 million shares outstanding and a further 6.5 million reserved. In such an early stage, the market is heavily influenced by communication — and a series of articles published on 8 June were explicitly labelled as paid promotional material. They contained no new revenue figures, signed customer contracts, or quarterly earnings, effectively marketing the company’s broader vision without the concrete financial updates that typically underpin a stock’s valuation.

Should investors sell immediately? Or is it worth buying Redwood AI?

The most headline-grabbing item is the proposed acquisition of Quantum.IQ, a cyber-security firm specialising in software that assesses encryption systems against future quantum attacks. The deal was outlined in a non-binding letter of intent dated 28 May and could involve the issuance of up to 14 million shares. That potential dilution is a key factor in the recent selling pressure: investors worry that adding new equity will further depress the stock, especially since the transaction remains contingent on due diligence and a definitive agreement is far from certain.

Where does that leave shareholders? The company has sketched out a broader story that extends well beyond drug discovery into defence, public safety, and quantum cryptography, but it has yet to deliver the operational proof points that would justify the narrative. Concrete milestones — such as commercial deployments of the AI chemistry tools, progress in the Q-SAFE programme, or a binding completion of the Quantum.IQ purchase — are still missing. Until those materialise, Redwood AI’s stock will remain tethered to the credibility of its announcements and the extreme volatility that has come to define its early days on the public market.

Ad

Redwood AI Stock: Buy or Sell?! New Redwood AI Analysis from June 9 delivers the answer:

The latest Redwood AI figures speak for themselves: Urgent action needed for Redwood AI investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 9.

Redwood AI: Buy or sell? Read more here...